Your session is about to expire
← Back to Search
Socially Assistive Robot for Low Vision
Phase 1
Recruiting
Led By Ava K Bittner, OD, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up for immediate robot: baseline, 1 month, 3 months, 6 months. for delayed/waitlist robot: baseline, 3 months, 6 months.
Awards & highlights
Study Summary
This trial is testing a robot's ability to help people with vision loss learn to use a new magnifier, with the goal of reducing visual disability.
Who is the study for?
This trial is for adults over 18 with any level of vision loss from ocular disease, who have received a magnification device from the UCLA Vision Rehabilitation Center. It's not suitable for those with life-limiting medical conditions, conflicting schedules, cognitive impairments, substance abuse issues, significant hearing loss or incompatible magnifier devices.Check my eligibility
What is being tested?
The study tests how a socially assistive robot can help people with low vision use their magnification devices more effectively and consistently when reading. The robot aims to motivate users and reinforce skills needed to proficiently use the magnifier.See study design
What are the potential side effects?
Since this trial involves a non-medical intervention (a socially assistive robot), traditional side effects associated with medications are not applicable. However, participants may experience frustration or lack of interest in interacting with the robot.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ for immediate robot: baseline, 1 month, 3 months, 6 months. for delayed/waitlist robot: baseline, 3 months, 6 months.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~for immediate robot: baseline, 1 month, 3 months, 6 months. for delayed/waitlist robot: baseline, 3 months, 6 months.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Activity Inventory
Secondary outcome measures
3-item UCLA Loneliness Scale
Almere
Duke Social Support Index
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate RobotExperimental Treatment1 Intervention
One month after study entry, participants will receive the robot at home for two months, followed by a three month observation period without the robot.
Group II: Delayed/Waitlist RobotActive Control1 Intervention
Three months after study entry, participants will receive the robot at home for three months.
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,276,831 Total Patients Enrolled
University of Southern CaliforniaOTHER
905 Previous Clinical Trials
1,596,258 Total Patients Enrolled
Ava K Bittner, OD, PhDPrincipal InvestigatorUCLA Stein Eye Institute; Vision Rehabilitation Center
3 Previous Clinical Trials
570 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of using drugs or alcohol excessively.The magnifier device can't be used with the beacon sensors because it doesn't have a way to hold it in your hand or a flat area to attach the sensor.You have received a magnification device from the UCLA Vision Rehabilitation Center.You have trouble hearing and cannot understand conversations over the phone or from a robot.You have any kind of vision loss because of an eye disease.
Research Study Groups:
This trial has the following groups:- Group 1: Immediate Robot
- Group 2: Delayed/Waitlist Robot
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What have been the findings regarding the efficacy of Socially Assistive Robot for Low Vision Rehabilitation in terms of safety?
"Our team at Power gives Socially Assistive Robot for Low Vision Rehabilitation a score of 1, as the data supporting its safety and efficacy is limited. This trial is in Phase 1."
Answered by AI
Are there any positions remaining for participants in this research endeavor?
"According to the clinicaltrials.gov website, this trial is actively enrolling patients and was originally posted on April 22nd 2022; with a subsequent update occurring on September 1st 2022."
Answered by AI
To what extent is the enrollment for this research endeavor being expanded?
"Affirmative, the information available on clinicaltrials.gov illustrates that this medical trial is actively enrolling candidates. Initially posted on April 22nd 2022, it has since been updated as of September 1st 2022 and calls for 20 participants from one specific site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger